These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [TRIALS OF A NEW ANTIHYPERTENSIVE, ALPHA-METHYL-DOPA (ALDOMET) WITH SPECIAL REFERENCE TO CHANGES IN RETINAL BLOOD FLOW]. MIKUNI M; KIMURA S; TAKESHIMA M Rinsho Ganka; 1963 Nov; 17():1249-56. PubMed ID: 14095961 [No Abstract] [Full Text] [Related]
4. COMPARISON OF ALPHA-METHYLDOPA WITH STANDARD ANTIHYPERTENSIVE THERAPY IN MAN. KAKAVIATOS N; CHUPKOVICH V; FINNERTY FA Am J Cardiol; 1964 Apr; 13():489-94. PubMed ID: 14136291 [No Abstract] [Full Text] [Related]
5. An investigation of alpha-methyl amino-acids and their derivatives on isolated tissue preparations. Gulati OD; Parikh HM; Ringe SY; Sherlekar ML Br J Pharmacol; 1970 Dec; 40(4):689-701. PubMed ID: 5495174 [TBL] [Abstract][Full Text] [Related]
6. [METHYLDOPA AND DECARBOXYLASE INHIBITION]. OFFERHAUS L; MUEHLEN AC; DE VRIES LA Ned Tijdschr Geneeskd; 1964 May; 108():966-8. PubMed ID: 14168782 [No Abstract] [Full Text] [Related]
7. Blood pressure and noradrenaline levels after treatment with alpha-methyldopa, alpha-methyldopamine and alpha-methyl-m-tyrosine. Henning M J Pharm Pharmacol; 1967 Nov; 19(11):775-9. PubMed ID: 4383705 [No Abstract] [Full Text] [Related]
8. TREATMENT OF HYPERTENSION. THE SPECIAL PLACE OF ALPHA-METHYLDOPA. A SHORT TERM STUDY. WEIL MH; BARBOUR BH Calif Med; 1963 Sep; 99(3):178-81. PubMed ID: 14047631 [TBL] [Abstract][Full Text] [Related]
9. ALPHA-METHYLDOPA IN ARTERIAL HYPERTENSION: CLINICAL, RENAL AND HEMODYNAMIC STUDIES. SANNERSTEDT R; BOJS G; VARNAUSKAS E; WERKOE L Acta Med Scand; 1963 Jul; 174():53-67. PubMed ID: 14042466 [No Abstract] [Full Text] [Related]
10. The effects of alpha-methyl-DOPA and alpha-methyl-metatyrosine on the metabolism of norepinephrine and serotonin in vivo. HESS SM; CONNAMACHER RH; OZAKI M; UDENFRIEND S J Pharmacol Exp Ther; 1961 Nov; 134():129-38. PubMed ID: 13907002 [No Abstract] [Full Text] [Related]
11. METHYLDOPA IN TREATMENT OF HYPERTENSION DUE TO CHRONIC RENAL DISEASE. LUKE RG; KENNEDY AC Br Med J; 1964 Jan; 1(5374):27-30. PubMed ID: 14071629 [No Abstract] [Full Text] [Related]
12. [EFFECT OF METHYLDOPA AND RESERPINE ON BLOOD PRESSURE AND SALT EXCRETION]. BIRKENHAEGER WH; GEERLING J; SMORENBERG-SCHOORL ME; OFFERHAUS L; BORST JG Ned Tijdschr Geneeskd; 1964 May; 108():968-9. PubMed ID: 14168783 [No Abstract] [Full Text] [Related]
13. Central dopamine and noradrenaline receptor activity of the amines formed from m-tyrosine, alpha-methyl-m-tyrosine and alpha-methyldopa. Andén NE; Butcher SG; Engel J J Pharm Pharmacol; 1970 Jul; 22(7):548-50. PubMed ID: 4395068 [No Abstract] [Full Text] [Related]
14. Hemodynamic effects of methyldopa (Aldomet) at rest and during exercise in patients with arterial hypertension. SANNERSTEDT R; VARNAUSKAS E; WERKO L Acta Med Scand; 1962 Jan; 171():75-82. PubMed ID: 14496972 [No Abstract] [Full Text] [Related]
15. ALPHA-METHYL DOPA FOR THE TREATMENT OF HYPERTENSION: CLINICAL AND PHARMACODYNAMIC STUDIES. WEIL MH; BARBOUR BH; CHESNE RB Circulation; 1963 Aug; 28():165-74. PubMed ID: 14051536 [No Abstract] [Full Text] [Related]
16. ON THE MECHANISM OF NORADRENALINE DEPLETION BY ALPHA-METHYL METATYROSINE AND METARAMINOL. ANDEN NE Acta Pharmacol Toxicol (Copenh); 1964; 21():260-71. PubMed ID: 14209617 [No Abstract] [Full Text] [Related]